LivaNova Reenters Medicare Fray Seeking VNS Depression Coverage
Executive Summary
The US Centers for Medicare and Medicaid Services opened a national coverage reconsideration analysis for vagus nerve stimulation for treatment-resistant depression on May 30, 11 years after it declined to cover the treatment for this indication.